Notice: Function Elementor\Core\Experiments\Manager::warn_removed_or_hidden_dependency was called incorrectly. Feature mega-menu depends on hidden experiment nested-elements. Please see Debugging in WordPress for more information. (This message was added in version 4.3.5.) in /home1/ocasiusm/medwire.ai/wp-includes/functions.php on line 6260
Danaher Appoints New Chief Technology & AI Officer, Life Sciences EVP – Medwire
Subscribe

Danaher Appoints New Chief Technology & AI Officer, Life Sciences EVP

By

Ava Lane

Disclaimer: Images on MEDWIRE.AI are AI-generated for illustrative purposes and are not affiliated with, endorsed by, or representative of any specific company, product, or technology.

Danaher (NYSE: DHR) announced two key leadership appointments to advance its digital transformation and Life Sciences division.

Martin Stumpe will become chief technology and AI officer, effective October 1, 2025. Stumpe, who joined last year as chief data and AI officer, reports directly to CEO Rainer Blair. He brings experience from Tempus, Google’s Cancer Pathology project, and NASA’s Kepler team.

Greg Milosevich is named executive vice president overseeing Life Sciences, effective July 1, 2025. Milosevich has led Danaher’s Life Sciences Innovations Group since 2021 and has held increasing responsibilities since joining via Molecular Devices in 2010.

“These appointments mark a pivotal step in accelerating Danaher’s integration of AI and driving Life Sciences growth,” said Blair.

Follow MEDWIRE.AI for leadership and innovation updates in MedTech.

RECOMMENDED READS

Stroke Risk After TAVR Remains Higher for Women
Stroke Risk After TAVR Remains Higher for Women
Pairing SAVR with Additional Heart Surgeries Raises Mortality Risk in Older Patients
Pairing SAVR with Additional Heart Surgeries Raises Mortality Risk...
Xvivo Enrolls First Patient in Heart Assist Transport CAP Study
Xvivo Enrolls First Patient in Heart Assist Transport CAP...
Nuwellis Terminates REVERSE HF Trial, Refocuses Ultrafiltration Strategy
Nuwellis Terminates REVERSE HF Trial, Refocuses Ultrafiltration Strategy
Vitamin D Supplements May Help Protect Against Cardiovascular Disease
Vitamin D Supplements May Help Protect Against Cardiovascular Disease
JenaValve Kicks Off First-Ever TAVR vs. SAVR Study for Aortic Regurgitation
JenaValve Kicks Off First-Ever TAVR vs. SAVR Study for...
Linkedin

Get the MEDWIRE.AI Newsletter

Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.

© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.

Subscribe